GTHP Financials 11/09/2014 10:06:39
Guided Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,179 3,410 3,622 3,364
Cost of Revenue 611 117 106 -
Gross Profit 568 3,293 3,516 3,364
Operating Expenses
Research and Development 2,742 3,227 2,779 1,805
Sales, General and Admin. 4,434 4,347 7,493 3,180
Non-Recurring Items - - - -
Other - - - -
Operating Income (6,606) (4,281) (6,756) (1,621)
Income From Continuing Operations
Add'l Income/Expense Items (564) - 192 2
Earnings Before Interest and Tax (7,170) (4,281) (6,564) (1,619)
Interest Expense 45 72 80 1,227
Earnings Before Tax (7,215) (4,353) (6,644) (2,846)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (7,215) (4,353) (6,644) (2,846)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,215) (4,353) (6,644) (2,846)
Preferred Stock and Other Adjustments (3,175) - - (1,700)
Net Income Applicable to Common Shareholders (10,390) (4,353) (6,644) (4,546)
Guided Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,179 3,410 3,622 3,364
Cost of Revenue 611 117 106 -
Gross Profit 568 3,293 3,516 3,364
Operating Expenses
Research and Development 2,742 3,227 2,779 1,805
Sales, General and Admin. 4,434 4,347 7,493 3,180
Non-Recurring Items - - - -
Other - - - -
Operating Income (6,606) (4,281) (6,756) (1,621)
Income From Continuing Operations
Add'l Income/Expense Items (564) - 192 2
Earnings Before Interest and Tax (7,170) (4,281) (6,564) (1,619)
Interest Expense 45 72 80 1,227
Earnings Before Tax (7,215) (4,353) (6,644) (2,846)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (7,215) (4,353) (6,644) (2,846)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,215) (4,353) (6,644) (2,846)
Preferred Stock and Other Adjustments (3,175) - - (1,700)
Net Income Applicable to Common Shareholders (10,390) (4,353) (6,644) (4,546)
